KR101108222B1 - 진통 작용을 가진 인다졸아마이드 - Google Patents

진통 작용을 가진 인다졸아마이드 Download PDF

Info

Publication number
KR101108222B1
KR101108222B1 KR1020057014055A KR20057014055A KR101108222B1 KR 101108222 B1 KR101108222 B1 KR 101108222B1 KR 1020057014055 A KR1020057014055 A KR 1020057014055A KR 20057014055 A KR20057014055 A KR 20057014055A KR 101108222 B1 KR101108222 B1 KR 101108222B1
Authority
KR
South Korea
Prior art keywords
acid
methyl
pharmaceutically acceptable
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020057014055A
Other languages
English (en)
Korean (ko)
Other versions
KR20050101541A (ko
Inventor
마리아 알레산드라 알리시
니콜라 카졸라
안젤로 구글리엘모티
구이도 푸로티
쥬세페 루나
로렌조 폴렌자니
Original Assignee
아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 filed Critical 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이
Publication of KR20050101541A publication Critical patent/KR20050101541A/ko
Application granted granted Critical
Publication of KR101108222B1 publication Critical patent/KR101108222B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020057014055A 2003-02-18 2004-01-26 진통 작용을 가진 인다졸아마이드 Expired - Fee Related KR101108222B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2003A000287 2003-02-18
IT000287A ITMI20030287A1 (it) 2003-02-18 2003-02-18 Indazolammidi dotate di attivita' analgesica metodo, per
PCT/EP2004/000647 WO2004074275A1 (en) 2003-02-18 2004-01-26 Indazolamides with analgesic activity

Publications (2)

Publication Number Publication Date
KR20050101541A KR20050101541A (ko) 2005-10-24
KR101108222B1 true KR101108222B1 (ko) 2012-02-08

Family

ID=32894157

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057014055A Expired - Fee Related KR101108222B1 (ko) 2003-02-18 2004-01-26 진통 작용을 가진 인다졸아마이드

Country Status (22)

Country Link
US (2) US7632849B2 (enExample)
EP (1) EP1594859B1 (enExample)
JP (1) JP4724651B2 (enExample)
KR (1) KR101108222B1 (enExample)
CN (2) CN101139341B (enExample)
AR (1) AR043186A1 (enExample)
AT (1) ATE471934T1 (enExample)
AU (1) AU2004213104B2 (enExample)
CA (1) CA2511984C (enExample)
DE (1) DE602004027792D1 (enExample)
DK (1) DK1594859T3 (enExample)
EA (1) EA009077B1 (enExample)
ES (1) ES2345983T3 (enExample)
GE (1) GEP20074075B (enExample)
IL (1) IL169285A (enExample)
IT (1) ITMI20030287A1 (enExample)
MX (1) MXPA05008730A (enExample)
PL (1) PL215870B1 (enExample)
PT (1) PT1594859E (enExample)
SI (1) SI1594859T1 (enExample)
UA (1) UA79537C2 (enExample)
WO (1) WO2004074275A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
CA2569654C (en) 2004-06-15 2010-12-21 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
US8815892B2 (en) 2008-03-25 2014-08-26 Affectis Pharmaceuticals Ag P2X7R antagonists and their use
ES2357682T3 (es) 2008-03-25 2011-04-28 Affectis Pharmaceuticals Ag Antagonistas de p2x7r novedosos y su utilización.
DK2243772T3 (da) * 2009-04-14 2012-02-13 Affectis Pharmaceuticals Ag Hidtil ukendte P2X7R-antagonister og deres anvendelse
CN104080781B (zh) 2012-02-21 2016-05-11 方济各安吉利克化学联合股份有限公司 1H-吲唑-3-甲酰胺化合物作为糖原合酶激酶3β抑制剂的用途
SI2817302T1 (sl) * 2012-02-21 2016-03-31 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A 1H-indazol-3-karboksamidne spojine kot inhibitorji glikogen sintaza-kinaze-3beta
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2905242C (en) 2013-03-15 2016-11-29 Pfizer Inc. Indole compounds that activate ampk
EP3790873B1 (en) 2018-05-07 2022-04-27 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
CN109336890B (zh) * 2018-11-17 2020-03-20 重庆文理学院 一种吲唑类衍生物的合成方法及抗肿瘤应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0732333A1 (en) 1995-03-16 1996-09-18 Eli Lilly And Company Indazolecarboxamides
EP0908459A1 (en) 1997-10-07 1999-04-14 Eli Lilly And Company 5-HT4 Agonists and antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705175A (en) 1969-04-01 1972-12-05 Egyt Gyogyszervegyeszeti Gyar Indazole-3-carboxylic amides
US5654320A (en) * 1995-03-16 1997-08-05 Eli Lilly And Company Indazolecarboxamides
KR19990022096A (ko) * 1995-05-31 1999-03-25 쇼다 오사무 모노시클릭 아미노기를 갖는 인다졸 유도체
US6096476A (en) * 1995-08-11 2000-08-01 Toray Industries, Inc. Direct drawing type waterless planographic original form plate
CN1104435C (zh) 1996-08-16 2003-04-02 史密丝克莱恩比彻姆有限公司 N－[(1－正丁基－4－哌啶基)甲基]－3,4－二氢－2H－[1,3] 噁嗪并[3,2－α]吲哚－10－甲酰胺及其盐的制备方法及在本方法中的中间体的制备方法
IT1291569B1 (it) 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
US6339087B1 (en) * 1997-08-18 2002-01-15 Syntex (U.S.A.) Llc Cyclic amine derivatives-CCR-3 receptor antagonists
US6407103B2 (en) * 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
EP1071668B1 (en) * 1998-04-21 2009-06-03 Bristol-Myers Squibb Pharma Company 5-aminoindeno[1,2-c]pyrazol-4-ones as anti-cancer and anti-proliferative agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0732333A1 (en) 1995-03-16 1996-09-18 Eli Lilly And Company Indazolecarboxamides
EP0908459A1 (en) 1997-10-07 1999-04-14 Eli Lilly And Company 5-HT4 Agonists and antagonists

Also Published As

Publication number Publication date
GEP20074075B (en) 2007-03-26
EP1594859B1 (en) 2010-06-23
CN101139341B (zh) 2010-12-08
ATE471934T1 (de) 2010-07-15
EA200501164A1 (ru) 2005-12-29
CA2511984C (en) 2011-01-18
DE602004027792D1 (de) 2010-08-05
US7632849B2 (en) 2009-12-15
KR20050101541A (ko) 2005-10-24
UA79537C2 (en) 2007-06-25
AU2004213104A1 (en) 2004-09-02
PT1594859E (pt) 2010-07-23
EA009077B1 (ru) 2007-10-26
CN101139341A (zh) 2008-03-12
HK1079199A1 (en) 2006-03-31
JP2006517932A (ja) 2006-08-03
ITMI20030287A1 (it) 2004-08-19
PL215870B1 (pl) 2014-02-28
ES2345983T3 (es) 2010-10-07
US20060052417A1 (en) 2006-03-09
CA2511984A1 (en) 2004-09-02
CN1742004A (zh) 2006-03-01
DK1594859T3 (da) 2010-10-11
AU2004213104B2 (en) 2010-07-08
WO2004074275A1 (en) 2004-09-02
SI1594859T1 (sl) 2010-10-29
AR043186A1 (es) 2005-07-20
JP4724651B2 (ja) 2011-07-13
CN100347168C (zh) 2007-11-07
IL169285A (en) 2012-08-30
MXPA05008730A (es) 2005-09-20
US20100048907A1 (en) 2010-02-25
US8519139B2 (en) 2013-08-27
PL377236A1 (pl) 2006-01-23
EP1594859A1 (en) 2005-11-16

Similar Documents

Publication Publication Date Title
KR101019313B1 (ko) Ｎ-[페닐(피페리딘-2-일)메틸]벤즈아미드의 유도체, 그의제조 방법 및 치료법에서의 그의 용도
EP1527048B1 (fr) Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
US8519139B2 (en) Indazolamides with analgesic activity
ES2601250T3 (es) Fármaco activo contra el dolor neuropático
KR101093048B1 (ko) 진통 작용을 가진 인다졸
JP5314597B2 (ja) 置換酒石酸の誘導体及びβ−セクレターゼ阻害剤を調製するための使用
US5373023A (en) Tetrahydronaphtalene derivatives, their preparation and pharmaceutical compositions containing them
WO2015046405A1 (ja) 鎮痛剤
US6670400B1 (en) Phenoxyethylamine derivatives having high affinity for the 5-HT1A receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
HUP9903928A2 (hu) Fenoxi-etil-amin új származékai,eljárás előállításukra, alkalmazásuk gyógyszerhatóanyagokként és ilyen vegyületeket tartalmazó gyógyászati készítmények
CN102099358A (zh) 具有血清素源性活性的化合物、制备它的方法和包含它的药物组合物
HK1079199B (en) Indazolamides with analgesic activity
HK1087705B (en) Indazoles having analgesic activity

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20141218

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20151130

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20161223

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20180114

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20180114

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301